Antibody Discovery & Engineering Services

The Curia Antibody Center offers a comprehensive suite of services for researchers seeking the discovery and engineering of potent and functional antibodies. This includes the identification, optimization, and characterization of novel antibody leads.

The Center leverages a combination of hybridoma and display-based technologies, with the specific approach tailored to each project's unique parameters such as scientific goals, timelines, and inherent challenges.

Curia's hybridoma platform employs diverse immunization strategies to maximize plasma titers, ultimately leading to the isolation of high-quality monoclonal antibodies with desired functional and specificity profiles. To further enhance success rates, the Center conducts meticulous target analysis using bioinformatics, literature, and patent data. This analysis identifies potential hurdles specific to the target antigen that may impact the discovery process. Additionally, clients receive continuous data updates throughout the campaign, enabling transparent Chain of Discovery tracking from initial immunizations to final mAb sequences.

Review our wide breadth of services and learn how Curia can support your antibody program from discovery through development and manufacturing.